PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27907860-5	2017	This was further supported using a flow-cytometry (Annexin V/propidium iodide assay), which revealed a significant increase in apoptotic cells in both the cell lines after the co-administration of VP-16 and Bcl-2 Aso using oMWCNTs-PEG hybrid, and fluorescence microscopy, which showed an increase in reactive oxygen species identified after Bcl-2 knock-down.	Propidium	61-77	BCL2 apoptosis regulator	Homo sapiens	207-212	
30623407-5	2019	The increase in Bcl2/Bax ratio increased the cell metabolic activity and decreased propidium iodide-positive cells.	Propidium	83-99	BCL2 apoptosis regulator	Homo sapiens	16-20	
26823806-4	2015	The expression levels of Bax and Bcl-2 proteins were detected by Annexin V/propidium iodide coupled staining.	Propidium	75-91	BCL2 apoptosis regulator	Homo sapiens	33-38	
16806009-2	2006	METHODS: Proliferation and apoptosis of A375 cell with bcl-2 ASODN treatment were evaluated by MTT colorimetric assay, laser scanning confocal microscope (LSCM), TUNEL and Annexin V/propidium iodide(PI), and the level of bcl-2 mRNA expression in A375 cell was detected by RT-PCR before and after being treated by bcl-2 ASODN.	Propidium	182-198	BCL2 apoptosis regulator	Homo sapiens	55-60	
8205548-8	1994	Analysis of propidium iodide-stained nuclei by flow cytometry after cisplatin or etoposide treatment revealed marked DNA degradation in vector-transfected controls whereas bcl-2 transfectants showed a dose-dependent inhibition of DNA degradation.	Propidium	12-28	BCL2 apoptosis regulator	Homo sapiens	172-177	
26820261-4	2016	The rates of cell proliferation and apoptosis, the cell cycle profiles and the mRNA expression of B-cell lymphoma 2 (Bcl-2) were detected using cell counting kit-8, multicaspase assays, propidium iodide staining and reverse transcription-quantitative polymerase chain reaction, respectively.	Propidium	186-202	BCL2 apoptosis regulator	Homo sapiens	117-122